EU panel backs 1st-line Sarclisa for transplant-eligible myeloma
A European Medicines Agency committee has recommended that Sarclisa (isatuximab), used in combination with standard-of-care medications, be approved for the treatment of adults newly…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
As a caregiver, I’m always on the lookout for myeloma research news
The word “caregiver” usually conjures up images of hands-on support: providing comfort, helping out with everyday tasks, and managing medications. However, for those of us…
EU panel backs Darzalex for high-risk smoldering multiple myeloma
A European Medicines Agency (EMA) committee recommended that Darzalex (daratumumab) given as an under-the-skin injection be approved for people with smoldering multiple myeloma (SMM)…
When words fail: The silence that falls after a myeloma diagnosis
I still remember what happened in 2022 after my mother received her myeloma diagnosis. I was sitting by her side in the hospital room.
Combination myeloma treatment shows promise in trial
Most people with hard-to-treat multiple myeloma who were given a combination treatment of Talvey (talquetamab-tgvs) and Tecvayli (teclistamab-cqyv) in a clinical trial were alive…
Why I continue to write about my experience as a caregiver
“Nobody is reading any of those essays you caregivers write,” a healthcare provider once told me. The following week, a stranger emailed me: “Your…
